“The Dysregulation of Mir-21 and Mir-143 As a Clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients With Gastrointestinal Sarcoma”. Journal of Pharmaceutical Negative Results 13, no. 3 (September 20, 2022): 20–25. Accessed July 19, 2024. https://pnrjournal.com/index.php/home/article/view/217.